Literature DB >> 20104582

The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt?

Xingshun Qi, Guohong Han, Daiming Fan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20104582     DOI： 10.1002/hep.23217

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

1.  An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty.

Authors:  Xingshun Qi; Xiaozhong Guo
Journal:  Arch Med Sci       Date:  2016-10-24       Impact factor: 3.318

2.  Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant).

Authors:  Yue-Meng Wan; Yu-Hua Li; Hua-Mei Wu; Zhi-Yuan Xu; Ying Xu; Li-Hong Yang; Xi-Nan Wu; Jin-Hui Yang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

3.  Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.

Authors:  Xingshun Qi; Guohong Han
Journal:  Hepatol Int       Date:  2011-12-01       Impact factor: 6.047

4.  Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.

Authors:  Xingshun Qi; Guohong Han; Chuangye He; Zhanxin Yin; Hongbo Zhang; Jianhong Wang; Jielai Xia; Hongwei Cai; Zhiping Yang; Ming Bai; Kaichun Wu; Daiming Fan
Journal:  Med Sci Monit       Date:  2012-08

5.  Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial.

Authors:  Xingshun Qi; Chuangye He; Zhanxin Yin; Zhengyu Wang; Hongbo Zhang; Liping Yao; Jianhong Wang; Jielai Xia; Hongwei Cai; Zhiping Yang; Ming Bai; Wengang Guo; Jing Niu; Kaichun Wu; Daiming Fan; Guohong Han
Journal:  BMJ Open       Date:  2013-07-11       Impact factor: 2.692

6.  Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis.

Authors:  Ting-Ting Jiang; Xiao-Ping Luo; Jian-Ming Sun; Jian Gao
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.